A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

July 9, 2025

Study Completion Date

December 31, 2025

Conditions

Dengue Fever

Interventions

BIOLOGICAL

TDV

TDV SC injection.

OTHER

Placebo

Placebo SC injection.

Trial Locations (5)

PS Clinic, Fukuoka

Saitama City Hospital, Saitama-shi

Sumida Hospital, Sumida-ku

OKURA Otolaryngology Clinic, Toshima-ku

Tamura Clinic, Tokyo